Latest News about Fda
Recent news which mentions Fda
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
February 24, 2025
From Benzinga
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version
February 24, 2025
From Benzinga
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
February 21, 2025
From Benzinga
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
February 19, 2025
From Benzinga
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official
February 19, 2025
From Benzinga
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
February 18, 2025
From Benzinga
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
February 18, 2025
From Benzinga
Robert F. Kennedy's Confirmation: Cannabis Advocates Question His New Vow To 'Follow The Science' On Marijuana's Harms
February 13, 2025
Tickers
NEWS
From Benzinga
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
From Benzinga
Zyn Changed Nicotine Forever - Are Cannabis Pouches The Next Big Thing?
February 12, 2025
From Benzinga
SpringWorks Therapeutics Secures FDA Approval For Second Cancer Drug
February 12, 2025
From Benzinga
Cannabis Takes On Superbugs: Could This New Drug 'Change Infection Treatment Forever'?
February 05, 2025
From Benzinga
Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop
February 04, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.